Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer

Weike Ma(Tianjin Medical University Cancer Institute and Hospital), Ming Gao(Tianjin Medical University Cancer Institute and Hospital)
Journal of Cancer
January 1, 2023
Cited by 7


Related Papers